Quantitative Analysis of Pseudoephedrine Tablets by UHPLC-MS
The Application Notebook
An effective UHPLC-MS method for high throughput separation, identification and quantitation of pseudoephedrine was developed on a Hypersil GOLD™ PFP 1.9 µm, 2.1 x 100 mm column.
An effective UHPLC-MS method for high throughput separation, identification and quantitation of pseudoephedrine was developed on a Hypersil GOLD™ PFP 1.9 µm, 2.1 x 100 mm column.
Pseudoephedrine and ephedrine are highly coveted by drug traffickers who use them to manufacture methamphetamine, for the illicit market (1). The separation and identification of pseudoephedrine from illicit drug mixtures, especially the mathaphetamine group compounds, will help to identify the sources and the manufacture pathway of the methamphetamine seized in the illicit market.
We report separation, identification, and quantitation of pseudoephedrine in a mixture of five illicit drugs/metabolites by ultra high performance liquid chromatography-mass spectrometry (UHPLC-MS).
Results and Discussion
Pseudoephedrine was identified as the major active ingredient for all the three brand name drugs by UHPLC-MS method (Figure 1). The peak retention time of 2.62 min for all three samples matched very well with the retention time of the pseudoephedrine standard at 2.60 min. The confirmation of pseudoephedrine at 2.6 min was further assured by the match of the MS spectra of the three samples with the pseudoephedrine standard.
Figure 1
An internal standard method was used for the quantitative determination of pseudoephedrine in its tablet form. The concentration of the assay samples determined (120.09 ppb) were in good agreement with the reported values (120 ppb).
Conclusions
A simple, fast, and reliable separation and identification method for five drugs (pseudoephedrine, ephedrine, amphetamine, methamphetamine and 3,4-MDMA) using UHPLC-MS is developed. The ppb (ng/mL) level sensitivity and accuracy by this method are more than sufficient to identify and quantify pseudoephedrine and/or other components in the seized illicit drug samples.
References
(1) Pseudoephedrine Notice, Office of Division Control, US Department of Justice, Drug Enforcement Administration.
Thermo Fisher Scientific Inc.
355 River Oaks Parkway, San Jose, CA 95134-1991
tel. +1 800-532-4752; fax +1 561-688-8731
Mitigating High Sample Volume Consumption in AAV Aggregate Analysis Using a Biozen™ dSEC-7 by SEC-FL
April 15th 2024This application note showcases a Biozen dSEC-7 SEC chemistry/fluorescence detector solution, offering reliable AAV aggregate analysis in under 10 minutes with as little as 0.5 µL of sample. Across four AAV serotypes, resolution between monomer and aggregates remains consistently high, emphasizing Biozen dSEC-7's efficiency and ability to maintain accurate detection at minimal injection volumes. Ideal for routine testing, this solution ensures precise measurement of a CQA with streamlined sample consumption.
Adeno-Associated Virus (AAV) Serotype Screen Using a Biozen™ dSEC-7 Size Exclusion Column
April 15th 2024With its 700 Å large pore silica particle and hydrophilic diol-type surface chemistry, Biozen dSEC-7 provides excellent resolution of monomer from dimer peaks in under 8 minutes across four different AAV serotypes. This capability is crucial for optimizing gene therapy biopharmaceuticals, ensuring thorough analytical scrutiny to select the most appropriate serotype(s) for enhanced therapeutic outcomes and immunogenic profiles.
